# Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

> **NCT03279302** · PHASE1 · COMPLETED · sponsor: **Zealand Pharma** · enrollment: 75 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Glepaglutide

## Key facts

- **NCT ID:** NCT03279302
- **Lead sponsor:** Zealand Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-04
- **Primary completion:** 2017-12-18
- **Final completion:** 2017-12-18
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03279302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03279302, "Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03279302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*